Genomenon Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
170

- Latest Deal Type
-
Series B1
- Latest Deal Amount
-
$5.46M
- Investors
-
25
Genomenon General Information
Description
Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software offers a set of diagnostic and discovery tools to identify disease-causing genomic variants and assists in treating cancer and other inheritable diseases, enabling physicians to improve patient outcomes.
Contact Information
Website
www.genomenon.comCorporate Office
- 206 East Huron Street
- Suite 114
- Ann Arbor, MI 48104
- United States
Corporate Office
- 206 East Huron Street
- Suite 114
- Ann Arbor, MI 48104
- United States
Genomenon Timeline
Genomenon Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
15. Later Stage VC (Series B1) | 16-May-2024 | $5.46M | Completed | Generating Revenue | ||
14. Later Stage VC (Series B) | 25-Feb-2022 | Completed | Generating Revenue | |||
13. Grant | 15-Feb-2022 | Completed | Generating Revenue | |||
12. Secondary Transaction - Private | 01-Aug-2021 | Completed | Generating Revenue | |||
11. Later Stage VC (Series A) | 16-Mar-2021 | Completed | Generating Revenue | |||
10. Debt - PPP | 07-Apr-2020 | Completed | Generating Revenue | |||
9. Grant | 01-May-2019 | Completed | Generating Revenue | |||
8. Seed Round | 08-Jan-2019 | Completed | Generating Revenue | |||
7. Seed Round | 07-Jul-2018 | $1.25M | $3.5M | Completed | Generating Revenue | |
6. Grant | 25-Apr-2017 | $1.8M | $2.25M | Completed | Generating Revenue |
Genomenon Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B-1 | ||||||||
Series B | ||||||||
Series A | ||||||||
Seed 1 | 1,303,131 | $0.000100 | $1.9 | $1.9 | 1x | $1.9 | 9.31% | |
Seed | 1,590,190 | $0.000100 | $1.71 | $1.71 | 1x | $1.71 | 11.36% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Genomenon Comparisons
Industry
Financing
Details
Genomenon Competitors (26)
One of Genomenon’s 26 competitors is Personal Genome Diagnostics, a Formerly VC-backed company based in Baltimore, MD.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD | ||||
DNAnexus | Venture Capital-Backed | Mountain View, CA | ||||
Nebula Genomics | Formerly VC-backed | Garden City, NY | ||||
Second Genome | Formerly VC-backed | Brisbane, CA | ||||
Deep Genomics | Venture Capital-Backed | Toronto, Canada |
Genomenon Patents
Genomenon Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230298769-A1 | Systems and methods for gene variant grouping and visualization | Pending | 10-Apr-2020 |
Genomenon Signals
Genomenon Investors (25)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Beringea | Venture Capital | Minority | ||
P93 Ventures | Venture Capital | Minority | ||
Spring Mountain Capital | Growth/Expansion | Minority | ||
The 4100 Group | Other Private Equity | Minority | ||
Small Business Innovation Research and Small Business Technology Transfer Programs | Government |
Genomenon Acquisitions (1)
Genomenon’s most recent deal was a Merger/Acquisition with Boston Genetics. The deal was made on 27-Jun-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Boston Genetics | 27-Jun-2023 | Merger/Acquisition | BPO/Outsource Services |
Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Boston Genetics | Cambridge, MA | 2019 |
Genomenon FAQs
-
When was Genomenon founded?
Genomenon was founded in 2014.
-
Where is Genomenon headquartered?
Genomenon is headquartered in Ann Arbor, MI.
-
What is the size of Genomenon?
Genomenon has 170 total employees.
-
What industry is Genomenon in?
Genomenon’s primary industry is Discovery Tools (Healthcare).
-
Is Genomenon a private or public company?
Genomenon is a Private company.
-
What is the current valuation of Genomenon?
The current valuation of Genomenon is
. -
What is Genomenon’s current revenue?
The current revenue for Genomenon is
. -
How much funding has Genomenon raised over time?
Genomenon has raised $36.8M.
-
Who are Genomenon’s investors?
Beringea, P93 Ventures, Spring Mountain Capital, The 4100 Group, and Small Business Innovation Research and Small Business Technology Transfer Programs are 5 of 25 investors who have invested in Genomenon.
-
Who are Genomenon’s competitors?
Personal Genome Diagnostics, DNAnexus, Nebula Genomics, Second Genome, and Deep Genomics are some of the 26 competitors of Genomenon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »